Prostate Cancer, Version 2.2014

James L. Mohler(Roswell Park Comprehensive Cancer Center), Philip W. Kantoff(Dana-Farber Brigham Cancer Center), Andrew J. Armstrong(Duke Cancer Institute), Robert R. Bahnson(The Ohio State University), Michael B. Cohen(University of Utah), Anthony V. D’Amico(Dana-Farber Brigham Cancer Center), James A. Eastham(Memorial Sloan Kettering Cancer Center), Charles A. Enke, Thomas A. Farrington(Education and Research Network), Celestia S. Higano(University of Washington), Eric M. Horwitz(Fox Chase Cancer Center), Christopher J. Kane(Moores Cancer Center), Mark H. Kawachi(Washington University in St. Louis), Michael Kuettel(Roswell Park Comprehensive Cancer Center), Timothy M. Kuzel, Richard J. Lee(Harvard University Press), Arnold W. Malcolm(Vanderbilt University), David C. Miller(University of Michigan–Ann Arbor), Elizabeth R. Plimack(Fox Chase Cancer Center), Julio M. Pow‐Sang(Moffitt Cancer Center), David Raben(University of Colorado Cancer Center), Sylvia Richey(University of Tennessee Health Science Center), Mack Roach(UCSF Helen Diller Family Comprehensive Cancer Center), Eric Rohren(The University of Texas MD Anderson Cancer Center), Stan Rosenfeld(University of California, San Francisco), Edward M. Schaeffer(Johns Hopkins University), Eric J. Small(UCSF Helen Diller Family Comprehensive Cancer Center), Guru Sonpavde(University of Alabama at Birmingham), Sandy Srinivas(Stanford University), Cy A. Stein(City Of Hope National Medical Center), Seth A. Strope(Washington University in St. Louis), Jonathan D. Tward(University of Utah), Dorothy A. Shead, Maria Ho
Journal of the National Comprehensive Cancer Network
May 1, 2014
10.6004/jnccn.2014.0072
Cited by 333

Abstract

Prostate cancer has surpassed lung cancer as the most common cancer in men in the United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer based on clinical evidence and expert consensus. NCCN Panel guidance on treatment decisions for patients with localized disease is represented in this version. Significant updates for early disease include distinction between active surveillance and observation, a new section on principles of imaging, and revisions to radiation recommendations. The full version of these guidelines, including treatment of patients with advanced disease, can be found online at the NCCN website.

Related Papers

No related papers found

Powered by citation graph analysis